Key result
An interactive patient smartphone support app significantly improved patient-registered drug adherence compared to a simplified tool at 6 months (nonadherence score 16.6 vs 22.8; P=0.025).
Why the study?
Does an interactive patient smartphone support app improve drug adherence and lifestyle changes in ticagrelor-treated myocardial infarction patients?
Population
174 ticagrelor-treated myocardial infarction (MI) patients, mean age 58 years, 81% men.
Comparison
Interactive patient support tool in addition to… vs Simplified tool in addition to usual post-MI care.
Design
RCT, Randomized
Follow-up
6 months
Authors
Loading...
Supports interactive smartphone apps to boost adherence post-MI; extends digital intervention evidence in secondary prevention.
RCT (n=174)
Yes
Does an interactive patient smartphone support app improve drug adherence and lifestyle changes in ticagrelor-treated myocardial infarction patients?
Absolute Event Rate: 16.6% vs 22.8%
p-value: p=0.025
An interactive smartphone app significantly improved self-reported drug adherence and patient satisfaction in post-MI patients compared to a simplified tool.
Johnston et al. (2016) conducted an RCT in Myocardial infarction (n=174). Interactive patient smartphone support app vs. Simplified tool in addition to usual post-MI care was evaluated on Composite nonadherence score measuring patient-registered ticagrelor adherence (p=0.025). An interactive patient smartphone support app significantly improved patient-registered drug adherence compared to a simplified tool at 6 months (nonadherence score 16.6 vs 22.8; P=0.025).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: